Skip to main content
Erschienen in: Journal of General Internal Medicine 10/2016

08.07.2016 | Capsule Commentary

Capsule Commentary on Callon et al., Assessing Problematic Substance Use in HIV Care: Which Questions Elicit Accurate Patient Disclosures?

verfasst von: Jeffrey L. Jackson, MD MPH

Erschienen in: Journal of General Internal Medicine | Ausgabe 10/2016

Einloggen, um Zugang zu erhalten

Excerpt

Adherence is an important factor in disease management for many chronic medical illnesses. Patients who are nonadherent to antiretroviral therapy risk increased viral resistance, opportunistic infections and disease acceleration.1 Substance abuse is commonly comorbid among patients with chronic disease and is a predictor for nonadherence in HIV treatment.2 Callon and colleagues found that how providers ask questions about substance abuse impacted the accuracy of patient answers.3 In their cohort, 162 patients actively abusing substances (as identified in a post-encounter interview) were audiotaped during visits with 56 providers. While substance use questions were asked less than half the time, open-ended (How’s the drinking going?”) and normalizing questions (“When was the last time you used?”) were 100% accurate in uncovering substance abuse, while closed-ended (“Have you used any cocaine?”) or biased questions (“Have you been clean?”) provided accurate answers less than half the time. The authors suggest that future research should focus on why providers fail to ask about substance use and whether universal screening of high-risk patients would be effective. …
Literatur
1.
Zurück zum Zitat Lucas GM, Griswold M, Gebo KA, Keruly J, Chaisson RE, Moore RD. Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy. Am J Epidemiol. 2006;163(5):412–20.CrossRefPubMed Lucas GM, Griswold M, Gebo KA, Keruly J, Chaisson RE, Moore RD. Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy. Am J Epidemiol. 2006;163(5):412–20.CrossRefPubMed
2.
Zurück zum Zitat Chander G, Himelhoch S, Moore RD. Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy. Drugs. 2006;66(6):769–89.CrossRefPubMed Chander G, Himelhoch S, Moore RD. Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy. Drugs. 2006;66(6):769–89.CrossRefPubMed
3.
Zurück zum Zitat Callon W, Beach MC, Saha S, Chander G, Wilson IB, Laws MB, Sharp V, Cohn J, Moore R, Korthuis PT. Assessing problematic substance use in HIV care: which questions elicit accurate patient disclosures? J Gen Intern Med. 2016. doi:10.1007/s11606-016-3733-z.PubMed Callon W, Beach MC, Saha S, Chander G, Wilson IB, Laws MB, Sharp V, Cohn J, Moore R, Korthuis PT. Assessing problematic substance use in HIV care: which questions elicit accurate patient disclosures? J Gen Intern Med. 2016. doi:10.​1007/​s11606-016-3733-z.PubMed
Metadaten
Titel
Capsule Commentary on Callon et al., Assessing Problematic Substance Use in HIV Care: Which Questions Elicit Accurate Patient Disclosures?
verfasst von
Jeffrey L. Jackson, MD MPH
Publikationsdatum
08.07.2016
Verlag
Springer US
Erschienen in
Journal of General Internal Medicine / Ausgabe 10/2016
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-016-3779-y

Weitere Artikel der Ausgabe 10/2016

Journal of General Internal Medicine 10/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.